Preventive effect of 3,4-dihydroxyacetophenone on atherosclerosis and role of visfatin expression

AIM: To observe the preventive effect of 3,4-dihydroxyacetophenone (DHAP) on atherosclerosis (AS) and the role of visfatin expression in ApoE(-/-) mice.METHODS: Eight-week-old normal mice were used in normal control group (n=8). Eight-week-old male ApoE (-/-) mice were randomly divided into 3 groups: AS group (n= 8, im. NS), DHAP treatment group (n=8, im. DHAP 10 mg·kg^-1·d^-1) and simvastatin treatment group (n=8, im. simvastatin 10 mg·kg^-1·d^-1). All mice were fed with Western diet (21% fat, 0.15% cholesterol) for 12 weeks. The blood samples were collected and the concentrations of blood lipids and visfatin were detected. The frozen sections of aortic root were stained with oil red O. The visfatin in atherosclerotic plaques at aortic roots was examined by Western blotting. The structures of smooth muscle cells and endothelial cells were observed under electron microscope. RESULTS: In DHAP-treated mice, the concentrations of visfatin, TG and TC were decreased, the formation of AS plaque was reduced, the injuries of smooth muscle cells and endothelia cells were attenuated. Visfatin was also decreased at atherosclerosis plaque in DHAP-treated mice.CONCLUSION: DHAP effectively prevents and treats AS by inhibiting the production of visfatin and reducing lipid.